RMC No. 59-2022: Publishes the March 4, 2022 letter from the Food and Drug Administration of the DOH endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act)

Files
Download this file

Summary

RMC No. 59-2022 publishes the March 4, 2022 letter from the Food and Drug Administration endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act).

Key points

  1. Letter published. The letter is from FDA OIC-Director General Dr. Oscar G. Gutierrez, Jr.
  2. Updates to the List. The List now includes certain medicines for cancer and COVID-19 treatment.

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.